Cargando…
Advance of promising targets and agents against COVID-19 in China
Autores principales: | Duan, Yongtao, Zhu, Hai-Liang, Zhou, Chongchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102657/ https://www.ncbi.nlm.nih.gov/pubmed/32198066 http://dx.doi.org/10.1016/j.drudis.2020.02.011 |
Ejemplares similares
-
The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023) -
Virus-, host-, immune-based targets for COVID-19 therapy
por: Liu, Wei, et al.
Publicado: (2020) -
Surrogate cytokine agonists: promising agents against COVID-19
por: Lin, Zemin, et al.
Publicado: (2022) -
Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021) -
Celastrol: A Promising Agent Fighting against Cardiovascular Diseases
por: Li, Zhexi, et al.
Publicado: (2022)